Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Daniel Keane

Alzheimer's 'wonder drug' Donanemab blocked for use on NHS over cost concerns

A drug that can slow the progression of Alzheimer's disease has been blocked for use on the NHS due to cost concerns - (PA)

A drug that can slow the progression of Alzheimer's disease has been blocked for use on the NHS due to cost concerns.

Donanemab was on Wednesday approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as a treatment for people in Britain with mild cognitive impairment, or those in the early stages of Alzheimer’s disease.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.